The study showed that the most common side effects were mild and temporary, including gastrointestinal (stomach and intestine) problems, like nausea and diarrhea
They found that the GR seemed to protect the mice from liver injury and was associated with a reduction in blood serum fat content
In contrast, long-acting agents appear to have a larger effect on lowering fasting glucose due to their effect to increase insulin release and inhibit glucagon release (Meier 2012)
These therapies hold promise as nonspecific immunomodulators, offering new approaches to regulating gut microbiota composition and potentially predicting patient responses to treatment
The combination of RIPK1 inhibitors such as Necrostatin-1 can further enhance this effect, providing novel therapeutic opportunities for cancer immunotherapy [265, 266]
Liraglutide's C-16 fatty acid provides weaker albumin binding, giving it only a 13-hour half-life